LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike
Organizer
Waters Corporation
Waters Corporation, the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry and thermal analysis innovations serving the life, materials and food sciences for nearly 60 years.
Tags
GC/MS
LC/MS
Logo of LinkedIn

Streamlined Development of Analytical Methods for Trace Level Genotoxic Impurities: Simplifying Workflows, Optimizing Performance and Mitigating Analytical Risk

RECORD | Already taken place We, 31.5.2023
Learn how your colleagues have upskilled their lab capabilities and technologies to elucidate the nature of unknown materials in complex drug substances, using a variety of analytical techniques.
Go to the webinar
Streamlined Development of Analytical Methods for Trace Level Genotoxic Impurities: Simplifying Workflows, Optimizing Performance and Mitigating Analytical Risk

Streamlined Development of Analytical Methods for Trace Level Genotoxic Impurities: Simplifying Workflows, Optimizing Performance and Mitigating Analytical Risk

Solving Problems That Matter: Nitrosamine Analysis

Expert Insight 3-Part Webinar Series: Upskilling Your Analytical Strategies for Nitrosamine Detection and Control to Proactively Address Safety in Pharmaceutical Product Development.

Unacceptable levels of N-nitrosamine impurities, which may increase the risk of cancer, have been found in some medications resulting in drug recalls, warning letters, and therapeutic shortages. To ensure that the residual level of nitrosamines in your drug products related to your drug development and manufacturing processes is within safe amounts, highly sensitive and specific analytical methods need to be used for the detection, characterization, and quantification of such impurities. Learn how your colleagues have upskilled their lab capabilities and technologies to elucidate the nature of unknown materials in complex drug substances, using a variety of analytical techniques.

In this timely virtual webinar series, pharmaceutical scientific experts discuss key analytical strategies on how to improve methods for nitrosamine impurity detection and characterization, and how sharing this expertise can help your pharmaceutical scientists support your product quality, safety, and efficacy

PART 3 | Streamlined Development of Analytical Methods for Trace Level Genotoxic Impurities: Simplifying Workflows, Optimizing Performance and Mitigating Analytical Risk

When a need for analytical testing follows a N-nitrosamines risk assessment, a new sensitive quantitative analysis method, specific to the pharmaceutical product, must be developed. The method development process can, however, be time consuming and challenging for even the very experienced analytical laboratory. The challenge of method development is exacerbated by prevalent Complex N-Nitrosamines Drug Substance Related Impurities (NDSRI) in pharmaceutical medicines where, in cases, the extremes of low acceptable thresholds must currently be controlled through testing using bespoke, very highly sensitive, and analytically robust methods.

This webinar focuses on the efficient development of optimised quantitative methods for the analysis of genotoxic impurities (GTIs), e.g. N-nitrosamines. As there is no ‘one size suits all’ in N-nitrosamine analytical methods, efficient development of quantitative methods can be facilitated through the implementation of streamlined workflows, where using performance technologies, quality products and consumables together will support a simplified end to end analytical workflow. In this webinar we will discuss systematic approach to quantitative method development with flexibility to meet todays and future testing needs. We will share how Waters latest analytical and sample preparations technologies align with quality, selective chemistries for simplified workflows in the development of optimised quantitative assays for GTIs and how these assays are further strengthened by the inherent mitigation of analytical errors.

Presenter: Amy Bartlett (Global Pharmaceutical Market Development, Waters Corporation)

Amy’s role in Pharmaceutical Market Development, within Waters’ Global Testing and Lab Services business, centers primarily on analytical solutions and workflows to support the Pharmaceutical Industry’s quantitative analysis needs. Specifically, Amy is focused on Waters Tandem Mass Spectrometry-centric solutions that tackle the industry's most pressing issues, including the challenging regulated analysis of trace level genotoxic impurities.

With nearly 17 years’ experience at Waters, Amy has established expertise in quantitative LC-MS/MS analysis and throughout this time led teams of experienced applications scientists providing application and scientific support to Waters' customers across a broad range of markets, applications, and technologies. Prior to joining Waters, Amy worked for several years in the pharmaceutical industry in Analytical Development and Discovery DMPK roles. She obtained a BSc in Chemistry from the University of Warwick, UK, before embarking on her career in the industry.

Waters Corporation
 

Related content

Online analysis of organic additives in copper plating process

Applications
| 2024 | Metrohm
Instrumentation
Electrochemistry
Manufacturer
Metrohm
Industries
Energy & Chemicals , Semiconductor Analysis

Orbitrap Ascend MultiOmics Tribrid mass spectrometer

Brochures and specifications
| 2024 | Thermo Fisher Scientific
Instrumentation
LC/HRMS, LC/MS/MS, LC/MS, LC/Orbitrap
Manufacturer
Thermo Fisher Scientific
Industries
Lipidomics, Metabolomics, Proteomics

8 points on how to care for columns

Technical notes
| 2024 | Watrex Prague
Instrumentation
Consumables, LC columns
Manufacturer
Watrex Prague
Industries
Others

Thermo Scientific Stellar mass spectrometer

Brochures and specifications
| 2024 | Thermo Fisher Scientific
Instrumentation
LC/MS, LC/MS/MS, LC/QTRAP
Manufacturer
Thermo Fisher Scientific
Industries
Proteomics , Metabolomics, Lipidomics, Pharma & Biopharma

Best practices for liposome analysis with the charged aerosol detector

Technical notes
| 2024 | Thermo Fisher Scientific
Instrumentation
HPLC
Manufacturer
Thermo Fisher Scientific
Industries
Lipidomics, Pharma & Biopharma
Other projects
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike